This federal contract award, valued at $5,025.15, was issued by the Medical Supply Chain division of the Defense Department to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose. This is a firm fixed price purchase order with a completion date of July 11, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical...
The U.S. government's Defense agency, specifically the Medical Supply Chain, has awarded a $4,020.12 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose, with a completion date of June 18, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale...
This federal contract award, valued at $2,010.06, was issued by the Medical Supply Chain division of the Department of Defense to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the purchase of 8510598440 - Naloxone Hydrochloride, a critical medication used to reverse opioid overdoses. The contract is a firm fixed-price purchase order with a completion date of May 13, 2024. The Maclean Group LLC is an...
This federal contract award, valued at $1,005.03, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded numerous prime federal...
The U.S. Department of Defense's Medical Supply Chain agency has awarded a firm fixed-price purchase order contract valued at $1,005.03 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has an ultimate completion date of May 10, 2024. The Maclean Group is an ISO 9001:2015 certified medical and...
This is a firm fixed price purchase order contract awarded by the Medical Supply Chain, a component of the Department of Defense, to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract, valued at $2,010.06, is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has a performance period ending on May 10, 2024. The Maclean Group is an ISO 9001:2015 certified...
The U.S. Defense Logistics Agency (DLA) awarded a $2,010.06 firm-fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride, a medication used to reverse opioid overdose. This contract has an ultimate completion date of May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several...
This federal contract award, valued at $1,005.03, was issued by the Defense agency Medical Supply Chain to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510987189 - Naloxone Hydrochloride, a medication used to reverse opioid overdose. The Maclean Group LLC has secured this firm-fixed price purchase order with an ultimate completion date of November 13, 2024. The company has established...
The U.S. Defense Logistics Agency awarded a firm-fixed-price purchase order contract worth $1,005.03 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride. The contract has an ultimate completion date of August 14, 2024 and was awarded on July 30, 2024. The Maclean Group, an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor, has a diverse portfolio of federal...
This federal contract award, valued at $1,005.03, was issued by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose, and has an ultimate completion date of October 3, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been...